QuickView for RNA polymerase II, core complex (biogroup)

1. L1000 CMAP - Cervical cancer HELA.311 cells with CRISPR induced gene knockouts
2. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens

There were no matches for RNA polymerase II, core complex

1. Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothel…
2. Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Pa…
3. Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Tr…
4. Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgki…
5. Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis